Ten Years of Service to People Affected by MS
We say farewell to a strong advocate for people living with MS after a decade of service with the MS Society of Canada. President & CEO Yves Savoie will be leaving the MS Society of Canada March 31, 2017.
A strong advocate for a patient-centered health system and a catalyst for increased involvement of people with MS in our research and advocacy initiatives, Yves is proud of the work he has accomplished in the past decade with the MS Society. He has been a top fundraiser in the MS Bike Tour and is a donor to the MS Society, reflecting his commitment to people affected by MS and the work of the MS Society.
Yves has accepted the position of Chief Executive Officer of Heart & Stroke Foundation of Canada. As CEO of Heart & Stroke, Yves will lead an organization that for more than 60 years has worked tirelessly to advance research, raise awareness and improve prevention and treatment.
Yves has a deeply personal connection with the work of the Heart & Stroke Foundation. His mother was paralyzed by strokes in the final years of her life and passed away in the last year. The opportunity to lead Heart & Stroke offers him a chance to honour her memory.
The MS Society’s first capital campaign – the endMS Campaign – reached its $60M goal with Yves’ careful guidance and leadership. He was one of the early participants in the development of a global initiative, the International Progressive MS Alliance, to accelerate the development of therapeutics in progressive MS. Yves is most proud of the Renewal Initiative, which launched in motion significant changes to better serve people with MS, to engage people with MS as full participants in the research enterprise, and to embrace the digital revolution to connect people with MS with each other, build our brand and develop and grow new revenue streams.
The staff and volunteers of the MS Society would like to thank Yves for his service to people affected by MS, and for his leadership in guiding the work of the MS Society over the past ten years. We wish Yves great success in his next chapter at Heart & Stroke, and thank him for the contributions he has made towards ending MS.